Unknown

Dataset Information

0

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children.


ABSTRACT: Inactivated mouse-brain-derived Japanese encephalitis vaccine has a worrisome safety profile and the live attenuated vaccine is unsuitable in immunodeficiency. This study aimed to evaluate the immunogenicity and safety of an inactivated chromatographically purified Vero-cell-derived JE vaccine (CVI-JE, Beijing P-3 strain) in children. 152 healthy Thai children, with an average (SD) age of 14.4 (3.8) months, received 3 doses of CVI-JE on days 0, 7-28, and one year. Homologous JE neutralizing antibody titers (NT) were measured. All subjects had seroprotection [geometric mean titer (GMT) 150] 28 days' post 2nd vaccination. The seroprotection rates at 1 year after primary series and and 1 month after the booster were 89.3% (GMT 49) and 100% (GMT 621), respectively. Local and systemic reactions-fever (17.6%), vomiting (8%), and poor appetite (5.3%)-were noted within 28 days' post-vaccination. All these symptoms were self-limited. CONCLUSIONS:CVI-JE is safe, immunogenic, and provided high NT.

SUBMITTER: Chanthavanich P 

PROVIDER: S-EPMC5893197 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children.

Chanthavanich Pornthep P   Limkittikul Kriengsak K   Sirivichayakul Chukiat C   Chokejindachai Watcharee W   Hattasingh Weerawan W   Pengsaa Krisana K   Surangsrirat Surachai S   Srisuwannaporn Termsang T   Kaewma Benjawan B   Yoksan Sutee S   Jun Gao G   Zhumu Bai B  

Human vaccines & immunotherapeutics 20180116 4


Inactivated mouse-brain-derived Japanese encephalitis vaccine has a worrisome safety profile and the live attenuated vaccine is unsuitable in immunodeficiency. This study aimed to evaluate the immunogenicity and safety of an inactivated chromatographically purified Vero-cell-derived JE vaccine (CVI-JE, Beijing P-3 strain) in children. 152 healthy Thai children, with an average (SD) age of 14.4 (3.8) months, received 3 doses of CVI-JE on days 0, 7-28, and one year. Homologous JE neutralizing anti  ...[more]

Similar Datasets

| S-EPMC4296691 | biostudies-literature
| S-EPMC7115602 | biostudies-literature
| S-EPMC8464466 | biostudies-literature
| S-EPMC7680781 | biostudies-literature
| S-EPMC5104688 | biostudies-literature
| S-EPMC4083074 | biostudies-literature
2021-01-21 | E-MTAB-9385 | biostudies-arrayexpress
| S-EPMC5433281 | biostudies-other
| S-EPMC4941394 | biostudies-literature
| S-EPMC4559679 | biostudies-literature